AVI BioPharma (AVII) Annoucnes Common Stock Offering
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Join SI Premium – FREE
AVI BioPharma, Inc. (NASDAQ: AVII) to offer common stock in an underwritten public offering.
AVI BioPharma also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any.
Lazard Capital Markets LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.
AVI BioPharma also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any.
Lazard Capital Markets LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parabilis Medicines closes $770.5 million IPO and concurrent private placement
- AES prices $1 billion senior notes offering with 2029 and 2033 maturities
- Super Micro Computer establishes $1.25 billion stock sale agreement
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Piper Jaffray, LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
